06/02/2004 - Much of the underlying technology that made the current commercial products of agricultural biotechnology possible was developed by small business and university-based innovators, and the scientists in these laboratories continue to push the technology forward. As we move towards the next generation of biotech products, however, some observers are concerned that our regulatory system can make it difficult for smaller enterprises to bring new products of that research to market. While most stakeholders generally agree that a clear and comprehensive regulatory system is necessary to ensure safety and to promote public confidence in the products of biotechnology, some have argued that the costs associated with compliance and the level of expertise required can put small business and university developers at a disadvantage and hinder introduction of smaller market products.
To illuminate these issues, the Pew Initiative on Food and Biotechnology and the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service co-sponsored a two-day workshop entitled Impacts of Biotech Regulation on Small Business and University Research: Possible Barriers and Potential Solutions. This workshop brought together a small group of experts representing a range of perspectives to examine the ways in which regulatory policies may have a disproportionate impact on small business and university innovation, and to consider possible avenues for addressing those concerns.
The views that emerged from the workshop are gathered here to help shed light on and provide direction for future exploration of these important issues.
Read the conference proceedings Impacts of Biotech Regulation on Small Business and University Research.
Read the conference highlights.